Atomera Provides Second Quarter 2025 Results
Atomera (NASDAQ:ATOM), a semiconductor materials and technology licensing company, reported its Q2 2025 financial results. The company recorded a net loss of $5.0 million ($0.17 per share), compared to a loss of $4.4 million ($0.16 per share) in Q2 2024. Cash position stood at $22.0 million as of June 30, 2025, down from $25.8 million at the end of 2024.
Key highlights include a strategic collaboration with Incize for GaN-on-Si technology advancement, joining the National Semiconductor Technology Center, and reaching 400 issued and pending patents in their intellectual property portfolio. The company reports increased customer wafer run activity across multiple technologies, which management believes will lead to future commercial agreements.
Atomera (NASDAQ:ATOM), un'azienda specializzata in materiali e licenze tecnologiche per semiconduttori, ha comunicato i risultati finanziari del secondo trimestre 2025. La societ脿 ha registrato una perdita netta di 5,0 milioni di dollari (0,17 dollari per azione), rispetto a una perdita di 4,4 milioni di dollari (0,16 dollari per azione) nel secondo trimestre 2024. La liquidit脿 disponibile ammontava a 22,0 milioni di dollari al 30 giugno 2025, in calo rispetto ai 25,8 milioni di fine 2024.
Tra i punti salienti, si segnala una collaborazione strategica con Incize per lo sviluppo della tecnologia GaN-on-Si, l'ingresso nel National Semiconductor Technology Center e il raggiungimento di 400 brevetti rilasciati e in attesa nel portafoglio di propriet脿 intellettuale. L鈥檃zienda riferisce un aumento delle attivit脿 di produzione wafer da parte dei clienti su pi霉 tecnologie, che la direzione ritiene porter脿 a futuri accordi commerciali.
Atomera (NASDAQ:ATOM), una empresa de materiales y licencias tecnol贸gicas para semiconductores, report贸 sus resultados financieros del segundo trimestre de 2025. La compa帽铆a registr贸 una p茅rdida neta de 5,0 millones de d贸lares (0,17 d贸lares por acci贸n), en comparaci贸n con una p茅rdida de 4,4 millones de d贸lares (0,16 d贸lares por acci贸n) en el segundo trimestre de 2024. La posici贸n de efectivo fue de 22,0 millones de d贸lares al 30 de junio de 2025, disminuyendo desde 25,8 millones a finales de 2024.
Los aspectos destacados incluyen una colaboraci贸n estrat茅gica con Incize para avanzar en la tecnolog铆a GaN-on-Si, la incorporaci贸n al National Semiconductor Technology Center y alcanzar 400 patentes emitidas y en tr谩mite en su portafolio de propiedad intelectual. La compa帽铆a reporta un aumento en la actividad de producci贸n de obleas por parte de los clientes en m煤ltiples tecnolog铆as, lo que la direcci贸n considera que conducir谩 a futuros acuerdos comerciales.
Atomera (NASDAQ:ATOM)電� 氚橂弰觳� 靻岇灛 氚� 旮办垹 霛检澊靹犾嫳 須岇偓搿�, 2025雲� 2攵勱赴 鞛 鞁れ爜鞚� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 靾滌啇鞁� 500毵� 雼煬(欤茧嫻 0.17雼煬)毳� 旮半頄堨溂氅�, 鞚措姅 2024雲� 2攵勱赴 靾滌啇鞁� 440毵� 雼煬(欤茧嫻 0.16雼煬)鞕� 牍勱祼霅╇媹雼�. 2025雲� 6鞗� 30鞚� 旮办 順勱笀 氤挫湢鞎§潃 2200毵� 雼煬搿�, 2024雲� 毵愳潣 2580毵� 雼煬鞐愳劀 臧愳唽頄堨姷雼堧嫟.
欤检殧 雮挫毄鞙茧電� GaN-on-Si 旮办垹 氚滌爠鞚� 鞙勴暅 Incize鞕�鞚� 鞝勲灥鞝� 順戨牓, National Semiconductor Technology Center 臧�鞛�, 攴鸽Μ瓿� 歆�鞝� 鞛偘甓� 韽姼韽措Μ鞓れ棎靹� 400瓯挫潣 霌彪 氚� 於滌洂 韸鬼棃 雼劚鞚� 韽暔霅╇媹雼�. 須岇偓電� 鞐煬 旮办垹 攵勳暭鞐愳劀 瓿犼皾鞚� 鞗澊韻� 臧�霃� 頇滊彊鞚� 歃濌皜頄堧嫟瓿� 氤搓碃頃橂┌, 瓴届榿歆勳潃 鞚搓矁鞚� 頄ロ泟 靸侅梾鞝� 瓿勳暯鞙茧 鞚挫柎歆� 瓴冹溂搿� 旮半寑頃橁碃 鞛堨姷雼堧嫟.
Atomera (NASDAQ:ATOM), une entreprise sp茅cialis茅e dans les mat茅riaux et la licence technologique pour semi-conducteurs, a publi茅 ses r茅sultats financiers du deuxi猫me trimestre 2025. La soci茅t茅 a enregistr茅 une perte nette de 5,0 millions de dollars (0,17 dollar par action), contre une perte de 4,4 millions de dollars (0,16 dollar par action) au deuxi猫me trimestre 2024. La tr茅sorerie s鈥櫭﹍evait 脿 22,0 millions de dollars au 30 juin 2025, en baisse par rapport 脿 25,8 millions 脿 la fin 2024.
Les points cl茅s incluent une collaboration strat茅gique avec Incize pour le d茅veloppement de la technologie GaN-on-Si, l鈥檃dh茅sion au National Semiconductor Technology Center, et l鈥檃tteinte de 400 brevets d茅livr茅s et en attente dans leur portefeuille de propri茅t茅 intellectuelle. L鈥檈ntreprise rapporte une augmentation de l鈥檃ctivit茅 de production de plaquettes clients sur plusieurs technologies, que la direction estime prometteuse pour de futurs accords commerciaux.
Atomera (NASDAQ:ATOM), ein Unternehmen f眉r Halbleitermaterialien und Technologielizenzierung, berichtete 眉ber seine Finanzergebnisse f眉r das zweite Quartal 2025. Das Unternehmen verzeichnete einen Nettoverlust von 5,0 Millionen US-Dollar (0,17 US-Dollar pro Aktie) im Vergleich zu einem Verlust von 4,4 Millionen US-Dollar (0,16 US-Dollar pro Aktie) im zweiten Quartal 2024. Die Barreserve belief sich zum 30. Juni 2025 auf 22,0 Millionen US-Dollar, gegen眉ber 25,8 Millionen US-Dollar Ende 2024.
Zu den wichtigsten Highlights z盲hlen eine strategische Zusammenarbeit mit Incize zur Weiterentwicklung der GaN-on-Si-Technologie, der Beitritt zum National Semiconductor Technology Center sowie das Erreichen von 400 erteilten und anh盲ngigen Patenten im geistigen Eigentumsportfolio. Das Unternehmen berichtet von einer gesteigerten Kundenaktivit盲t bei Wafer-L盲ufen 眉ber mehrere Technologien hinweg, von der das Management zuk眉nftige kommerzielle Vereinbarungen erwartet.
- Strategic collaboration with Incize for GaN-on-Si technology development
- Expanded intellectual property portfolio to 400 issued and pending patents
- Joined National Semiconductor Technology Center to accelerate U.S. chip innovation
- Increased customer wafer run activity across multiple technologies
- Net loss increased to $5.0 million from $4.4 million year-over-year
- Cash position decreased by $3.8 million in six months to $22.0 million
- Adjusted EBITDA loss widened to $4.0 million from $3.6 million year-over-year
Insights
Atomera reported widening losses and declining cash position despite technological advancements and strategic partnerships.
Atomera's Q2 2025 results reveal concerning financial metrics alongside promising operational developments. The company reported a net loss of
The cash position declined to
On the positive side, Atomera has strengthened its strategic positioning through a collaboration with Incize to advance GaN-on-Si technology for RF and power devices, which represents a growing market segment. The company also joined the National Semiconductor Technology Center, potentially enhancing its industry connections and technological credibility. The intellectual property portfolio expansion to 400 patents provides a strong foundation for future licensing opportunities.
CEO Scott Bibaud's statement about "heavy customer wafer run activity" suggests pre-revenue technology validation work is ongoing with multiple potential customers. However, the lack of revenue figures in the release implies these activities haven't yet translated into substantial commercial agreements. The widening losses indicate Atomera continues to invest heavily in R&D while still pursuing commercialization of its semiconductor materials technology.
LOS GATOS, CA / / August 5, 2025 / Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the second quarter ended June 30, 2025.
Recent Company Highlights
Announced a strategic collaboration with Incize to advance GaN-on-Si technology for next-gen RF and power devices
Joined National Semiconductor Technology Center to accelerate U.S. chip innovation
Reached 400 issued and pending patents in intellectual property portfolio
Management Commentary
"As we continue to expand our ecosystem of industry partners and bring exciting new technology to the industry, we are seeing growing interest from potential customers," said Scott Bibaud, President and CEO. "Right now, Atomera is in a period of heavy customer wafer run activity across multiple technologies that we are confident will lead us to future commercial agreements."
Financial Results
The Company incurred a net loss of (
The Company had
The total number of shares outstanding was 31.1 million as of June 30, 2025.
Second Quarter 2025 Results Webinar
Atomera will host a live video webinar today to discuss its financial results and recent progress.
Date: Tuesday, Aug. 5, 2025
Time: 2:00 p.m. PT (5:00 p.m. ET)
Webcast: Accessible at
Note about Non颅-GAAP Financial Measures
In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.
About Atomera Incorporated
Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology鈩� (MST庐), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at .
Safe Harbor
This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues and we have not yet commenced principal revenue producing operations, thus subjecting us to all of the risks inherent in an early-stage enterprise途 (2) the risk that STMicroelectronics does not proceed with qualification of MST in its manufacturing process or does not take MST-enabled products to market, (3) risks related to our ability to successfully complete the milestones in our joint development agreements or, even if successfully completed, to reach a commercial distribution license with our JDA customers; (4) risks related to our ability to advance licensing arrangements with our integration licensees to royalty-based manufacturing and distribution licenses or our ability to add other licensees; (5) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology途 (6) our ability to protect our proprietary technology, trade secrets and know颅how and (7) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on March 4, 2025. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.
-- Financial Tables Follow -
Atomera Incorporated
Condensed Balance Sheets
(in thousands, except per share data)
June 30, | March 31, | December 31, | ||||||||||
2025 | 2025 | 2024 | ||||||||||
(Unaudited) | (Unaudited) | |||||||||||
ASSETS | ||||||||||||
Current assets: | ||||||||||||
Cash and cash equivalents | $ | 22,026 | $ | 24,123 | $ | 25,778 | ||||||
Short-term investments | - | - | 995 | |||||||||
Accounts receivable | - | - | 6 | |||||||||
Interest receivable | 63 | 81 | 73 | |||||||||
Prepaid expenses and other current assets | 659 | 335 | 240 | |||||||||
Total current assets | 22,748 | 24,539 | 27,092 | |||||||||
Property and equipment, net | 50 | 52 | 59 | |||||||||
Long-term prepaid maintenance and supplies | 30 | 91 | 91 | |||||||||
Security deposit | 14 | 14 | 14 | |||||||||
Operating lease right-of-use asset | 155 | 218 | 280 | |||||||||
Financing lease right-of-use-asset | 1,087 | 1,338 | 1,588 | |||||||||
Total assets | $ | 24,084 | $ | 26,252 | $ | 29,124 | ||||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||
Current liabilities: | ||||||||||||
Accounts payable | $ | 665 | $ | 761 | $ | 492 | ||||||
Accrued expenses | 207 | 195 | 239 | |||||||||
Accrued payroll related expenses | 649 | 402 | 1,328 | |||||||||
Current operating lease liability | 124 | 184 | 260 | |||||||||
Current financing lease liability | 1,148 | 1,314 | 1,253 | |||||||||
Deferred revenue | - | - | 4 | |||||||||
Total current liabilities | 2,793 | 2,856 | 3,576 | |||||||||
Long-term operating lease liability | - | - | 22 | |||||||||
Long-term financing lease liability | - | 113 | 449 | |||||||||
Total liabilities | 2,793 | 2,969 | 4,047 | |||||||||
Commitments and contingencies | - | - | - | |||||||||
Stockholders' equity: | ||||||||||||
Preferred stock | ||||||||||||
Common stock: | 31 | 31 | 31 | |||||||||
Additional paid-in capital | 252,956 | 249,981 | 246,565 | |||||||||
Other comprehensive income(loss) | - | - |
| |||||||||
Accumulated deficit | (231,696 | ) | (226,729 | ) | (221,520 | ) | ||||||
Total stockholders' equity | 21,291 | 23,283 | 25,077 | |||||||||
Total liabilities and stockholders' equity | $ | 24,084 | $ | 26,252 | $ | 29,124 | ||||||
Atomera Incorporated
Condensed Statements of Operations
(Unaudited)
(in thousands, except per share data)
Three Months Ended | Six Months Ended | |||||||||||||||||||
June 30, | March 31, | June 30, | June 30, | |||||||||||||||||
2025 | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||
Revenue | $ | - | $ | 4 | $ | 72 | $ | 4 | $ | 90 | ||||||||||
Cost of revenue | (62 | ) | - | (74 | ) | (62 | ) | (107 | ) | |||||||||||
Gross margin | (62 | ) | 4 | (2 | ) | (2 | ) | (17 | ) | |||||||||||
Operating expenses | ||||||||||||||||||||
Research and development | 3,004 | 3,255 | 2,589 | 6,259 | 5,447 | |||||||||||||||
General and administrative | 2,048 | 2,088 | 1,832 | 4,136 | 3,643 | |||||||||||||||
Selling and marketing | 141 | 124 | 207 | 265 | 557 | |||||||||||||||
Total operating expenses | 5,193 | 5,467 | 4,628 | 10,660 | 9,647 | |||||||||||||||
Loss from operations | (5,255 | ) | (5,463 | ) | (4,630 | ) | (10,718 | ) | (9,664 | ) | ||||||||||
Other income (expense) | ||||||||||||||||||||
Interest income | 234 | 270 | 185 | 504 | 390 | |||||||||||||||
Accretion income | - | 6 | 47 | 6 | 93 | |||||||||||||||
Interest expense | (18 | ) | (21 | ) | (35 | ) | (39 | ) | (74 | ) | ||||||||||
Other income, net | 72 | (1 | ) | 72 | 71 | 72 | ||||||||||||||
Total other income (expense), net | 288 | 254 | 269 | 542 | 481 | |||||||||||||||
Net loss | $ | (4,967 | ) | $ | (5,209 | ) | $ | (4,361 | ) | $ | (10,176 | ) | $ | (9,183 | ) | |||||
Net loss per common share, basic and diluted | $ | (0.17 | ) | $ | (0.17 | ) | $ | (0.16 | ) | $ | (0.34 | ) | $ | (0.35 | ) | |||||
Weighted average number of common shares outstanding, basic and diluted | 30,397 | 30,243 | 26,467 | 30,321 | 26,253 | |||||||||||||||
Atomera Incorporated
Reconciliation to Non-GAAP EBITDA
(Unaudited)
Three Months Ended | Six Months Ended | |||||||||||||||||||
June 30, | March 31, | June 30, | June 30, | |||||||||||||||||
2025 | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||
Net loss (GAAP) | $ | (4,967 | ) | $ | (5,209 | ) | $ | (4,361 | ) | $ | (10,176 | ) | $ | (9,183 | ) | |||||
Depreciation and amortization | 12 | 12 | 13 | 24 | 30 | |||||||||||||||
Stock-based compensation | 1,278 | 1,009 | 987 | 2,287 | 2,011 | |||||||||||||||
Interest income | (234 | ) | (270 | ) | (185 | ) | (504 | ) | (390 | ) | ||||||||||
Accretion income | - | (6 | ) | (47 | ) | (6 | ) | (93 | ) | |||||||||||
Interest expense | 18 | 21 | 35 | 39 | 74 | |||||||||||||||
Other income, net | (72 | ) | 1 | (72 | ) | (71 | ) | (72 | ) | |||||||||||
Net loss non-GAAP EBITDA | $ | (3,965 | ) | $ | (4,442 | ) | $ | (3,630 | ) | $ | (8,407 | ) | $ | (7,623 | ) | |||||
Investor Contact:
Bishop IR
Mike Bishop
(415) 894-9633
[email protected]
SOURCE: Atomera, Inc
View the original on ACCESS Newswire
FAQ
What were Atomera's (ATOM) Q2 2025 financial results?
What strategic partnerships did Atomera announce in Q2 2025?
How many patents does Atomera (ATOM) currently have?
What is Atomera's current cash position as of Q2 2025?
How many shares of Atomera (ATOM) were outstanding in Q2 2025?
